Cargando…
Synergistic Membrane Disturbance Improves the Antibacterial Performance of Polymyxin B
Drug-resistant Gram-negative bacteria pose a serious threat to public health, and polymyxin B (PMB) is clinically used as a last-line therapy for the treatment of infections caused by these pathogens. However, the appearance of PMB resistance calls for an effort to develop new approaches to improve...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611124/ https://www.ncbi.nlm.nih.gov/pubmed/36297894 http://dx.doi.org/10.3390/polym14204316 |